AI-generated summary
The authors ran a double-blind randomized trial of photobiomodulation (low-level laser) in 65 people with knee osteoarthritis who completed the study, comparing it with sham and no-intervention groups. They report significant pain reductions and WOMAC improvements in the laser group, with no significant changes in the other groups. The authors describe the treatment as effective, but this summary reports only their findings.
- Participants
- 65
- Who or what was studied
- Adults with symptomatic knee osteoarthritis, both sexes; 73 initially enrolled and 65 analyzed
- Wavelengths
- 790 nm
- Limits stated in the abstract
- The abstract does not describe the sample size calculation, follow-up duration, or how the sham condition was kept blinded to participants.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 790 nm
- Power
- 120 mW
- Total energy
- 4 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Osteoarthritis, Laser, Low-level laser therapy, Randomized controlled trial, Sham, Visual analogue scale, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.